Getagraph.com logo
S&P 500
(-0.16%) 5 179.64 points
Dow Jones
(0.20%) 38 962 points
Nasdaq
(-0.36%) 16 273 points
Oil
(0.61%) $78.86
Gas
(-1.18%) $2.18
Gold
(-0.05%) $2 323.00
Silver
(0.31%) $27.63
Platinum
(-0.24%) $986.05
USD/EUR
(0.14%) $0.931
USD/NOK
(0.12%) $10.91
USD/GBP
(0.12%) $0.800
USD/RUB
(0.19%) $91.62

リアルタイムの更新： Orchid Pharma Limited [ORCHPHARMA.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-08)

Expected move: +/- 3.90%

最終更新日時8 5月 2024 @ 18:59
25% discount on Stockinvest.us - Use code: Podcast

3.70% INR 1 032.45

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India...

Stats
本日の出来高 37 101.00
平均出来高 202 767
時価総額 52.36B
EPS INR0 ( 2024-05-07 )
Last Dividend INR3.00 ( 2012-09-13 )
Next Dividend INR0 ( N/A )
P/E 36.29
ATR14 INR1.731 (0.17%)

ボリューム 相関

長: -0.15 (neutral)
短: -0.64 (weak negative)
Signal:(49.1) Neutral

Orchid Pharma Limited 相関

10 最も正の相関
10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Orchid Pharma Limited 相関 - 通貨/商品

The country flag -0.01
( neutral )
The country flag 0.00
( neutral )
The country flag -0.37
( neutral )
The country flag 0.16
( neutral )
The country flag -0.55
( weak negative )
The country flag -0.19
( neutral )

Orchid Pharma Limited 財務諸表

Annual 2022
収益: INR6.66B
総利益: INR2.81B (42.24 %)
EPS: INR11.35
FY 2022
収益: INR6.66B
総利益: INR2.81B (42.24 %)
EPS: INR11.35
FY 2022
収益: INR5.60B
総利益: INR2.33B (41.69 %)
EPS: INR-0.350
FY 2021
収益: INR4.50B
総利益: INR2.10B (46.68 %)
EPS: INR-28.55

Financial Reports:

No articles found.

Orchid Pharma Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Orchid Pharma Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.51 - low (49.98%) | Divividend Growth Potential Score: 2.52 - No dividend growth expected in the near future
Information
First Dividend INR2.67 2002-07-16
Last Dividend INR3.00 2012-09-13
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 11 --
Total Paid Out INR36.67 --
Avg. Dividend % Per Year 0.00% --
Score 1.67 --
Div. Sustainability Score 4.51
Div.Growth Potential Score 2.52
Div. Directional Score 3.52 --
Next Divdend (Est)
 (2024-06-17)
INR0 Estimate 0.00 %
Dividend Stability
0.03 Very Bad
Dividend Score
1.67
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2002 INR0 0.00%
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SOBHA.NS Dividend Junior 2023-07-28 Annually 18 0.43%
MMP.NS Dividend Junior 2023-08-18 Annually 4 0.49%
HDFC.NS Dividend Junior 2023-05-16 Annually 23 0.85%
BHAGCHEM.NS Dividend Junior 2023-07-27 Annually 4 0.14%
RAIN.NS Dividend Junior 2023-05-19 Annually 18 0.39%
KIRLOSBROS.NS Dividend Junior 2023-07-25 Annually 17 0.99%
EMMBI.NS Dividend Junior 2023-08-04 Annually 14 0.28%
AKSHARCHEM.NS No Dividend Player 2023-09-20 Annually 7 0.34%
SUPRAJIT.NS Dividend Junior 2023-09-18 Semi-Annually 20 0.45%
NBIFIN.NS Dividend Junior 2023-08-11 Sporadic 8 0.01%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1451.5007.1010.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1311.5009.6510.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM5.211.0009.189.18[3 - 30]
operatingCashFlowPerShareTTM12.632.005.7910.00[0 - 30]
freeCashFlowPerShareTTM12.632.003.697.37[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.4151.0006.426.42[0.2 - 0.8]
operatingProfitMarginTTM0.1311.0009.389.38[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.51

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM42.971.0005.760[1 - 100]
returnOnEquityTTM0.1312.509.7810.00[0.1 - 1.5]
freeCashFlowPerShareTTM12.632.005.797.37[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM12.632.005.7910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-1.1441.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07891.000-0.5280[0.1 - 0.5]
Total Score2.52

Orchid Pharma Limited

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。